HOME >> MEDICINE >> NEWS
OHSU Cancer Institute shows findings of immunotherapy vaccine in prostate cancer patients

PORTLAND, Ore. -- Data from an ongoing study designed to explore the biologic and clinical activity of cancer immunotherapy sipuleucel-T, or Provenge, in patients with early stage recurrent prostate cancer who have a rising serum prostate specific antigen (PSA) level, but who have not yet developed metastatic disease will be presented by Oregon Health & Science University Cancer Institute researchers.

The study showed that sipuleucel-T did not significantly delay the time it took for a patient's PSA to reach a value of 3 ng/ml, the primary endpoint of the study, but it did show a prolongation in prostate-specific antigen doubling time (PSADT). In addition, there was a trend observed in slowing the time to metastatic disease for patients who received sipuleucel-T compared with those who received placebo, but this early trend did not reach statistical significance. The findings will be presented Saturday, June 2, at 8 a.m. (CDT) at the 43rd Annual Meeting of the American Society of Clinical Oncologists (ASCO) in Chicago.

"While there was no delay in the time to PSA recurrence, we did observe a slowing in the rate of rise of serum PSA in exploratory analyses. Additional follow-up is needed to determine if this effect on PSA will translate into patient benefits," said Tomasz Beer, M.D., lead investigator, director of the Prostate Cancer Research program at the OHSU Cancer Institute; and associate professor of medicine, (hematology/medical oncology) OHSU School of Medicine.

The ongoing trial, known as P-11, is a double-blind, multi-center, randomized, placebo-controlled study involving 176 men, all of whom had prostatectomies and then had recurrent cancer as detected by a rise in the serum tumor marker, PSA. After three months of hormone therapy, 117 men received sipuleucel-T and 59 received placebo.

Sipuleucel-T was found to have a favorable safety profile. The most common side effects seen more commonly in sipuleucel-T-t
'"/>

Contact: Christine Decker
deckerch@ohsu.edu
503-494-8231
Oregon Health & Science University
2-Jun-2007


Page: 1 2 3

Related medicine news :

1. American Cancer Society to hold third annual Virtual Relay For Life in Second Life
2. Cancer research summaries
3. Cancer on the agenda of the Portuguese EU Council Presidency
4. Tony Hunter receives Robert. J. and Claire Pasarow Award for Cancer Research
5. OHSU Cancer Institute, VA researchers find way to identify which men need a second biopsy
6. OHSU Cancer Institute researcher identifies protein marker for prostate cancer survival
7. Ireland Cancer Center researcher lays out benefits of aspirin to prevent colon cancer
8. Mayo Clinic Cancer Center researcher finds mold by-product kills multiple myeloma
9. Margaret Foti receives AACR Award for Leadership and Extraordinary Achievements in Cancer Research
10. Cancer-fighting foods, supplements explored in day-long symposium, March 25
11. Cancer vaccine innovator honored with prestigious Florey Medal

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/14/2018)... ... 2018 , ... Gastro Health, LLC (“Gastro Health”), one of ... Simon Frisch and Chris Weinstein, who have been appointed Senior Vice President, Strategic ... time of tremendous growth for the group, which has increased its physician headcount ...
(Date:8/14/2018)... ... August 14, 2018 , ... Eagle Merchant ... a leading provider of residential and commercial recreational surfacing products across the country. ... with products used across a wide range of markets and customers. Founded in ...
(Date:8/11/2018)... OVERLAND PARK, Kan. (PRWEB) , ... August 10, ... ... Gout Gone, an industry leader in Gout Relief. , What is gout? This ... the lower extremities as a result of high levels of uric acid. Other ...
(Date:8/11/2018)... ... August 11, 2018 , ... Financial Voyages LLC CEO Pamela ... of the Year-Business category in The 15th Annual International Business Awards®. , The ... organizations worldwide – public and private, for-profit and non-profit, large and small - ...
(Date:8/9/2018)... ... August 09, 2018 , ... Balboa ... a new verification process that substance abuse providers must pass in order to ... can reach more people to help.” , Helping people is what Balboa ...
Breaking Medicine News(10 mins):
(Date:8/15/2018)... (PRWEB) , ... August 15, 2018 , ... ... to their expansive lineup of casters. The newly designed Diamond Series features ... and stability. Manufactured with an antimicrobial compound injected into a thermoplastic resin ...
(Date:8/14/2018)... OXNARD, Calif. (PRWEB) , ... August 14, 2018 ... ... completion of Harvest Academy, their first-ever summer harvest employment and hands-on educational program ... were currently enrolled in a high school, junior college or university, spent a ...
(Date:8/11/2018)... ... August 11, 2018 , ... ... Monday, August 13, with fun, games and gifts. Left-Handers are possibly the world’s ... for right-handers. Having endured centuries of prejudice, countless indignities and inconveniences, left-handers quietly ...
Breaking Medicine Technology:
Cached News: